Contraception
RSSArticles
-
New Research on Advance Provision Reveals Interest and Use in United States Since 2022
Interest in advance provision of abortion medication was high even before the U.S. Supreme Court overturned Roe v. Wade, according to recent research. Many of those interested in advance provision were more likely to be highly motivated to prevent pregnancy. They had been using highly effective contraceptives, were well-educated, had private insurance, and were not poor.
-
As Uncertainty Looms, More People Request Advance Provision of Mifepristone
Interest in advance provision of abortion medications mifepristone and misoprostol has increased dramatically in the post-Roe era. It remains popular as a U.S. Supreme Court case looms over whether mifepristone should remain available. Advance provision is one tool to help expand access to the medication.
-
Improve Screening and Retesting for Trichomoniasis
Infection by the protozoan Trichomonas vaginalis is the most common nonviral sexually transmitted infection, with an estimated 6.8 million cases in the United States annually. It can go undiagnosed because most infected people (up to three out of four) do not experience symptoms. Left undiagnosed and untreated, trichomoniasis can increase the risk of pelvic inflammatory disease, infertility, and acquiring HIV and other STIs.
-
National Screening Guidelines for Chlamydia
Reproductive and sexual health providers could reference evidence-based national guidelines for chlamydia screening and care, including guidelines from the U.S. Preventive Services Task Force, the Centers for Disease Control and Prevention, and the American Academy of Family Physicians.
-
Best Practices Needed in Screening and Treating Chlamydia
Chlamydia infection affects more than 1.7 million people each year, making it the most common bacterial STI. Using a screening tool and checklist, a family planning clinic found success in improving the chlamydia screening rate, identifying more cases of the STI, and making patient visits more efficient by reducing time spent on visits.
-
New Study Shows Oral Contraceptives Decrease Risk of Hypothyroidism
When researchers decided to explore the link between hormonal birth control and the risk of hypothyroidism, they made a surprising discovery: Contrary to earlier evidence, hormonal contraception decreases the risk of developing hypothyroidism.
-
Mental Health Screening Needed for Optimal Contraceptive Counseling
Mental health conditions are common among people of reproductive age. Still, both physicians and patients may have misconceptions about using hormonal contraception if patients are diagnosed with depression or other mental health issues. New research suggests that barriers to effective contraceptive use should be addressed, and clinicians need to dispel myths about the negative psychiatric impacts of hormonal contraceptives.
-
Health Department Increases IUD Provision at Clinics
Alabama has one of the highest proportions of pregnant people who do not want to be pregnant, many of whom are low-income and live in contraceptive deserts. A new study revealed that a public health commitment to providing intrauterine devices at Title X clinics helped increase access to long-acting reversible contraception across the state.
-
The Pandemic Did Not Affect Single-Visit LARC Insertion
Adolescents who used public insurance and were seeing a non-OB/GYN provider had lower odds of a single-visit placement of long-acting reversible contraception, new research shows.
-
Policy Changes Helped Increase LARC Use
National health statistics and new research point to increased interest in and use of long-acting reversible contraception (LARC). One in four women reported using LARC, according to the 2015-2019 National Survey of Family Growth.